|
FAQs - Frequently Asked Questions
BD Gentest Antibody Products
Below are the answers to many frequently asked questions submitted by
our customers. If the following does not address your questions please
contact info_gentest@bd.com.
What is included in an antibody
kit?
How many experiments can I perform with one immunoinhibition
kit?
How many experiments can
I perform with one Western blotting kit ?
Can I order the primary
antisera separately from the other kit components for a discounted price?
For a Western blot, what
other materials do I need to purchase?
What products do you recommend?
What is the
predicted molecular weight (estimated migration on SDS-PAGE) of this protein?
How specific is this antisera?
Why do the DAIICHI inhibitory antibody kits contain
normal immune serum, whereas the BD Gentest inhibitory antibody kits contain
Tris buffer?
Do you sell control sera separately?
Q: What is included in an antibody kit?
A: We provide antibody kits for Western
blotting (immunoblotting) or inhibition. These kits are manufactured by
BD Biosciences. DAIICHI PURE CHEMICALS CO., LTD. also provides single
vials of antiserum for use in Western blotting and inhibition.
- BD Gentest Inhibiton kit
A BD Gentest Inhibition kit contains 0.4 ml primary antisera and
1 ml 25 mM Tris pH 7.5 (for use as a diluent).
- BD Gentest Western blotting kit
Each BD Gentest Western blotting kit contains enough primary and
secondary antisera (0.4 ml or more) to perform at least 20 mini blots
(200 ml working reagent). Qualitative positive (and negative) controls
are sold separately.
Q: How many experiments can
I perform with one immunoinhibition kit?
A: The number of experiments that
can be performed is dependent on the inhibitory antibody used and the
sensitivity of the detection method. DAIICHI inhibitory antibodies contain
0.2 ml antisera. BD Gentest kits contain 0.4 ml antisera.
DAIICHI Inhibition Antisera
| Cat. No. |
Description |
*No. µl antiserum |
No. µg microsomes |
| 458131 |
Anti-rat CYP1A2 for inhibition (Human and Rat CYP1A1/1A2) |
40 |
200 |
| 458223 |
Anti-rat CYP3A2 for inhibition (Human and Rat CYP3A) |
20 |
200 |
| 458210 |
Antiserum for human CYP2D6 inhibition |
20 |
100 |
* for maximum inhibition
BD Gentest Inhibition Kits
| Cat. No. |
Description |
*No. µl antiserum |
No. µg microsomes |
| 458106 |
MAB-2A6; Monoclonal antibody to CYP2A6 |
2 |
100 |
| 458306 |
IH-MAB-2A6; Monoclonal antibody inhibitory to CYP2A6 |
2 |
100 |
| 458312 |
MAB-1A2; Monoclonal antibody inhibitory to CYP1A2 |
5 |
100 |
| 458321 |
MAB-2E1; Monoclonal antibody inhibitory to CYP2E1 |
2 |
100 |
| 458326 |
MAB-2B6; Monoclonal antibody inhibitory to CYP2B6 |
5 |
100 |
| 458328 |
IH-MAB-2C8; Monoclonal antibody inhibitory to CYP2C8 |
5 |
100 |
| 458334 |
MAB-3A4; Monoclonal antibody inhibitory to CYP3A4 |
10 |
100 |
| 458366 |
IH-MAB-2D6; Monoclonal antibody inhibitory to CYP2D6 |
2 |
100 |
Q: How many experiments can
I perform with one Western blotting kit?
A: Each Western blotting kit contains
enough primary antisera (0.2 ml or more) to perform at least 20 mini blots
(200 ml working reagent). In many cases twice as many blots can be performed
when very sensitive developing techniques (enhanced chemiluminescence)
are used. Details can be found on individual data sheets.
Q: Can I order the primary
antisera separately from the other kit components for a discounted price?
A: The primary antisera is not sold
separately from the other kit components because the essential cost of
the kit comes from the development and characterization of that primary
antisera.
Q: For a Western blot, what
other materials do I need to purchase?
A: For Western blotting kits and DAIICHI
vials of antiserum, you will need to purchase a qualitative positive control,
developing agent, and buffer components separately.
Note: The buffer components necessary for blocking, washing, and antibody
dilution are dependent on the antibody used. Exact blotting conditions
for each antibody are defined on their product data sheets. You must consult
those sheets for appropriate buffers and blotting conditions.
Q: What products do you recommend?
A: Our recommendations are shown below.
Q: What is the predicted molecular weight (estimated
migration on SDS-PAGE) of this protein?
A: The following molecular weight
designations have been predicted based on the amino acid sequence of each
enzyme. The apparent molecular weight, as deduced from mobility on an
SDS PAGE, may differ from the predicted molecular weight. When an apparent
mobility is known to differ from the predicted molecular weight, it is
noted in the table.
Predicted Molecular Weight
|
Enzyme
|
Molecular Weight (KD)
|
| Human CYP1A1 |
58.165 |
| Human CYP1A2 |
58.294 |
| Human CYP1B1 |
60.831 |
| Human CYP2A6 |
56.541 |
| Human CYP2B6 |
56.278 |
| Human CYP2C8 |
55.824 |
| Human CYP2C9 |
55.574 |
| Human CYP2C18 |
55.742 |
| Human CYP2C19 |
55.945 |
| Human CYP2D6 |
55.801 |
| Human CYP2E1 |
56.849 |
| 1Human CYP3A4 |
57.299 |
| 1Human CYP3A5 |
57.108 |
| Human CYP3A7 |
57.470 |
| Human CYP4A11 |
59.347 |
| Human CYP4B1 |
59.019 |
| Human OR |
76.558 |
1Human CYP3A4 (57.3 KD) migrates more quickly
(further) than human CYP3A5 (57.1 KD) on an SDS PAGE even though their
predicted molecular weight indicates otherwise.
|
Enzyme
|
Molecular Weight (KD)
|
| Rat CYP1A1 |
59.393 |
| Rat CYP1A2 |
58.293 |
| Rat CYP1B1 |
60.556 |
| Rat CYP2A1 |
56.009 |
| Rat CYP2A2 |
56.345 |
| Rat CYP2B1 |
55.933 |
| Rat CYP2B2 |
55.944 |
| Rat CYP2C6 |
56.002 |
| Rat CYP2C11 |
57.181 |
| Rat CYP2C12 |
55.918 |
| Rat CYP2C13 |
55.859 |
| Rat CYP2D1 |
57.175 |
| Rat CYP2D2 |
56.683 |
| Rat CYP2E1 |
56.626 |
| Rat CYP3A1 |
57.917 |
| Rat CYP3A2 |
57.811 |
| Rat CYP4A1 |
58.214 |
| Rat CYP4A2 |
57.968 |
| Rat CYP4A3 |
58.232 |
| Rat OR |
76.831 |
Q: How specific is this antisera?
A: Antibody specificity tables are
available in Technical Resources.
Human P450 Inhibitory Antibodies
Human P450 Immunoblotting Antibodies
Human UGT Immunoblotting Antibodies
Human FMO Immunoblotting Antibodies
Rat P450 Inhibitory Antibodies
Rat P450 Immunoblotting Antibodies
Dog P450 ELISA Antibodies
Q: What is the difference between
DAIICHI inhibitory antisera and BD Gentest inhibitory antibody kits?
A: Currently, the principal difference
between the DAIICHI inhibitory antibodies and the BD Gentest inhibitory
antibodies is that DAIICHI are whole serum-based polyclonal antisera,
whereas BD Gentest are ascites-based monoclonal antibodies. The total
protein concentration of the polyclonal antisera is 80 to 100 mg/ml. About
0.1 to 2.5% of these serum proteins represent specific antibody. Therefore,
the use of normal or nonimmune serum as a diluent or negative control
is recommended to ensure that any effect seen is not just a nonspecific
protein binding effect.
All of our monoclonal antibodies are standardized with
25 mM Tris pH 7.5 to a protein concentration of 10 mg/ml (from about 30
mg/ml initially). About 10 to 50% of the total protein in ascites is immunoglobulin
with 90% being specific antibody. Therefore we would use Tris buffer or
a nonspecific ascites preparation as a negative control.
Q: Do you sell control sera
separately?
A: We do not sell control sera separately.
An unrelated antisera or normal sera from the same animal can be used
as a negative control. Normal sera can be obtained from a vendor such
as Jackson ImmunoResearch Laboratories (610-869-4024; cuserjaxn@aol.com;
West Grove, PA USA).
|